Article and Video CATEGORIES
This is the last part of my discussion with Dr. Matthew Horton, a pathologist with a special training and a great expertise in lung pathology who works here in Seattle at a company called CellNetix.
We focus in this last one on the increasing focus on molecular markers in making clinical decisions and how this is changing the relationship of pathologists with oncologists, as well as the need for pathologists to provide this information in a timely way.
dr-horton-pt-3-transition-to-molecular-pathology-audio-podcast
dr-horton-pt-3-transition-to-molecular-pathology-transcript
dr-horton-pt-3-transition-to-molecular-pathology-figures
Next, we'll turn to coverage of imaging issues in cancer management.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Waiting for my appointment with oncologist this morning. Thank you for the response. It helps. <3
It sounds like you’re thinking of this in a very appropriate way. Specifically, it sounds like the growth of the nodule is rather modest, though keep in mind that the change...
Hi and welcome to GRACE. I'm sorry your mom is having this difficulty. An indwelling catheter is used when the pleura space continually fills and the catheter is always there to...
Hi Oaktowngrrl, Welcome to Grace. I'm so sorry you're going through this.
Finding a reputable dedicated thoracic surgeon for lung surgery might be difficult, as it is a complex and...
Hi Blaze,
As much as I hate to say it, Welcome back Blaze. It sounds like you're otherwise feeling good and enjoying life which is a wonderful place to be. ...